These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. Yui Y, Hattori R, Takatsu Y, Nakajima H, Wakabayashi A, Kawai C, Kayama N, Hiraku S, Inagawa T, Tsubojima M. Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196 [Abstract] [Full Text] [Related]
3. Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046). Tomoda H. Am Heart J; 1986 Oct; 112(4):696-704. PubMed ID: 3532743 [Abstract] [Full Text] [Related]
8. In vivo inhibition of thromboxane synthetase in infarcted canine myocardium. McCluskey ER, Kramer JB, Corr PB, Needleman P. Biochem Biophys Res Commun; 1984 Jun 15; 121(2):552-7. PubMed ID: 6539597 [Abstract] [Full Text] [Related]
15. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model. Garvin PJ, Niehoff ML, Robinson SM, Heisler T, Salinas-Madrigal L, Contis J, Solomon H. Transplantation; 1996 May 27; 61(10):1429-34. PubMed ID: 8633364 [Abstract] [Full Text] [Related]
16. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis. Nihei C, Metoki H, Shimanaka Y, Kawahara R, Komatsu O, Oike Y, Kanazawa T, Izawa M, Kaneko H, Hoshi Y. Adv Prostaglandin Thromboxane Leukot Res; 1987 May 27; 17B():953-7. PubMed ID: 2960210 [No Abstract] [Full Text] [Related]
17. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist. Nichols WW, Mehta J, Wargovich TJ, Franzini D, Lawson D. Angiology; 1989 Mar 27; 40(3):209-21. PubMed ID: 2537051 [Abstract] [Full Text] [Related]
18. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs. Murayama K, Kasai H, Adachi T, Utsunomiya O, Ouchi H. Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar 27; 35(3):344-50. PubMed ID: 6339650 [Abstract] [Full Text] [Related]
19. Pulmonary vascular response to thrombin: effects of thromboxane synthetase inhibition with OKY-046 and OKY-1581. Garcia-Szabo R, Kern DF, Malik AB. Prostaglandins; 1984 Dec 27; 28(6):851-66. PubMed ID: 6543018 [Abstract] [Full Text] [Related]
20. Thromboxane A2 in acute myocardial infarction. Walinsky P, Smith JB, Lefer AM, Lebenthal M, Urban P, Greenspon A, Goldberg S. Am Heart J; 1984 Oct 27; 108(4 Pt 1):868-72. PubMed ID: 6485997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]